CTRE

CareTrust REIT Inc

Add to Watchlist

Advanced Chart

36.150

+0.59(1.659%)1D

Line

Candle

YTD

High

36.550

Open

35.950

VWAP

36.18

Vol

2.11M

Mkt Cap

3.54B

Low

35.5679

Amount

76.20M

EV/EBITDA(TTM)

29.21

Total Shares

142.06M

6.41B

EV/OCF(TTM)

24.01

P/S(TTM)

14.91

CareTrust REIT, Inc. is a self-administered real estate investment trust (REIT). The Company is engaged in the ownership, acquisition, development and leasing of skilled nursing, senior housing and other healthcare-related properties. It has a portfolio of long-term net-leased properties across the United States and United Kingdom. The Company owns, directly or indirectly through joint ventures, and leases to independent operators skilled nursing facilities (SNFs), multiservice campuses, assisted living facilities (ALFs) and independent living facilities (ILFs), consisting of operational beds and units located in various states with the highest concentration of properties by rental income located in California, Texas and Tennessee. Its facilities include Camarillo, San Juan Capistrano, Barton Creek, Bayshire Carlsbad, El Centro Post-Acute Care, Bayshire Rancho Mirage, Weiser Care, Wellspring Health and Rehabilitation of Cascadia, Cornerstone Rehab & Health Care Center, and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

110.20M

+59.96%

119.20M

+54.04%

123.10M

+41.59%

Estimates Revision

The market is revising No Change the revenue expectations for CareTrust REIT, Inc. (CTRE) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 9.88%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+9.88%

In Past 3 Month

6 Analyst Rating

-12.03% Downside

Wall Street analysts forecast CTRE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CTRE is 31.80 USD with a low forecast of 28.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

1 Sell

Moderate Buy

-12.03% Downside

Current: 36.150

Low

28.00

Averages

31.80

High

35.00

-12.03% Downside

Current: 36.150

Low

28.00

Averages

31.80

High

35.00

Cantor Fitzgerald

Neutral

initiated

$37

2025-10-01

Reason

Cantor Fitzgerald

Price Target

$37

2025-10-01

initiated

Neutral

Reason

Cantor Fitzgerald initiated coverage of CareTrust REIT with a Neutral rating and $37 price target. The firm initiated coverage of the U.S. REITs, including nine property sectors and 40 stocks. Although there isn't widespread enthusiasm for a REIT recovery in 2026 just yet, Cantor believes the industry could be well-positioned over the next 12 to 24 months, the analyst tells investors in a research note. The firm's top property sector calls include Office, Industrial, Healthcare and Net Lease, but is incrementally more cautious on Multifamily and Hotels.

Raymond James

Jonathan Hughes

Strong Buy

maintain

$35 -> $39

2025-09-02

Reason

Raymond James

Jonathan Hughes

Price Target

$35 -> $39

2025-09-02

maintain

Strong Buy

Reason

Raymond James analyst Jonathan Hughes raised the firm's price target on CareTrust REIT to $39 from $35 and keeps a Strong Buy rating on the shares. The recession-resilient and defensive, needs-driven nature of healthcare is increasingly top of mind in the current uncertain environment, the analyst tells investors in a research note. The firm notes that REITs with smaller asset bases, strong balance sheets, plentiful external growth opportunities, and favorable costs of capital, much like CareTrust, can be powerful recipes for robust earnings, net asset value, dividend growth, and outperformance.

KeyBanc

Austin Wurschmidt

Overweight

maintain

$33 -> $36

2025-08-14

Reason

KeyBanc

Austin Wurschmidt

Price Target

$33 -> $36

2025-08-14

maintain

Overweight

Reason

KeyBanc analyst Austin Wurschmidt raised the firm's price target on CareTrust REIT to $36 from $33 and keeps an Overweight rating on the shares after the company announced a 15.5M share follow-on issuance, which was upsized to 20M shares for gross proceeds of $640M, or $736M including the over-allotment option. The firm expects proceeds will be used to fund the company's $600M investment pipeline, repay its existing line balance, and create incremental capacity to fund future investments.

RBC Capital

Outperform

maintain

$32 -> $36

2025-08-11

Reason

RBC Capital

Price Target

$32 -> $36

2025-08-11

maintain

Outperform

Reason

RBC Capital raised the firm's price target on CareTrust REIT to $36 from $32 and keeps an Outperform rating on the shares after its Q2 results. The company has remained active deploying capital accretively given its year-to-date volume and sizeable investment pipeline, the analyst tells investors in a research note.

BMO Capital

Market Perform

maintain

$33 -> $35

2025-05-26

Reason

BMO Capital

Price Target

$33 -> $35

2025-05-26

maintain

Market Perform

Reason

BMO Capital raised the firm's price target on CareTrust REIT to $35 from $33 and keeps a Market Perform rating on the shares. The firm made changes to its models for a number of REITs due to interest rate changes, recent results, and/or discussions with company management.

Raymond James

Jonathan Hughes

initiated

2025-05-08

Reason

Raymond James

Jonathan Hughes

Price Target

2025-05-08

initiated

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for CareTrust REIT Inc (CTRE.N) is 19.75, compared to its 5-year average forward P/E of 341.77. For a more detailed relative valuation and DCF analysis to assess CareTrust REIT Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

341.77

Current PE

19.75

Overvalued PE

1683.65

Undervalued PE

-1000.10

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

14.86

Current EV/EBITDA

14.82

Overvalued EV/EBITDA

16.12

Undervalued EV/EBITDA

13.60

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

11.10

Current PS

11.69

Overvalued PS

13.29

Undervalued PS

8.91